Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 Nov 2020
Historique:
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 11 11 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-76581-6 PMID: 33168924 PMC: PMC7652880
pubmed: 33168924
doi: 10.1038/s41598-020-76581-6
pii: 10.1038/s41598-020-76581-6
pmc: PMC7652880
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

19806

Commentaires et corrections

Type : ErratumFor

Auteurs

Kanako Miyano (K)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.

Moeko Eto (M)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, 278-8510, Japan.

Suzuro Hitomi (S)

Division of Physiology, Kyushu Dental University, Fukuoka, 803-8580, Japan.

Takashi Matsumoto (T)

Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan.

Seiya Hasegawa (S)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.

Ayane Hirano (A)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.

Kaori Nagabuchi (K)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.

Noriho Asai (N)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.

Miaki Uzu (M)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.

Miki Nonaka (M)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.

Yuji Omiya (Y)

Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan.

Atsushi Kaneko (A)

Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan.

Kentaro Ono (K)

Division of Physiology, Kyushu Dental University, Fukuoka, 803-8580, Japan.

Hideaki Fujii (H)

Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.

Yoshikazu Higami (Y)

Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, 278-8510, Japan.
Translational Research Center, Research Institute of Science and Technology, Tokyo University of Science, Chiba, 278-8510, Japan.

Toru Kono (T)

Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan.

Yasuhito Uezono (Y)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp.
Division of Supportive Care Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp.
Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp.

Classifications MeSH